Curing Cancer Takes A Global Village: Cancer Moonshot Pathways

BeiGene CEO John Oyler BeiGene Note: President Joe Biden in February launched a “Cancer Moonshot” initiative that aims to reduce the death rate from cancer by 50% in the next 25 years. This is a part ...

Why Not To Worry, China Chip Stocks Rally, Week In Review

China Last Night KraneShares Week in Review Asian equities ended a volatile week mostly higher as China released mixed economic data showing that the services economy expanded above expectations while...

Fed Fears Weigh On Foreign Sentiment Though Not Chinese Sentiment

China Last Night KraneShares Key News Thailand chose the right day to be on a market holiday as Asian equities took a one-two punch from Fed Gov Brainerd’s statement that US interest rates will rise i...

China securities regulator on U.S.-listed Chinese stocks audit delisting

The China Securities Regulatory Commission and U.S. securities regulators have been locked in a dispute over allowing U.S. review of Chinese company audits, threatening delisting in coming years. Cost...

Meituan Leads Hong Kong Internet Rebound

China Last Night KraneShares Key News Asian equities were mixed as the Hang Seng outperformed, gaining +1.31% led by internet stocks as the Hang Seng TECH Index gained +2.62%. Meituan (3690 HK) jumped...

U.S.- listed China shares are tumbling again with Alibaba down 5%

China’s economic headwinds and slowing retail sales growth could weigh on Alibaba’s fiscal second quarter earnings when it reports numbers on Thursday. Costfoto | Barcroft Media | Getty Im...

Chinese Stocks Plunge After SEC Stokes Delisting Concerns

A further step by the Securities and Exchange Commission toward forcing companies from China off American exchanges helped trigger the worst decline in U.S.-listed Chinese stocks since the global fina...

Biotech Stocks: Why China-Based Plays, Like BeiGene, Are In Trouble

Regulators started a two-year clock Thursday to force China-based companies to comply with U.S. trading rules — leading three biotech stocks to crumble. X BeiGene (BGNE), Zai Lab (ZLAB) and Hutchmed (...

Local Investors Less Pessimistic, Week In Review

China Last Night KraneShares Week in Review Last weekend was the start of China’s dual sessions, from which China’s GDP growth target of 5.5% for 2022 was announced along with a slew of supportive eco...

US-Listed Chinese Companies React To Today’s HFCAA Announcement & Fading Optimisim On Ukraine Truce

China Last Night KraneShares Key News Asian equities followed US equities higher overnight on hopes for a peaceful resolution to the Ukraine crisis as oil prices plummeted. Worth noting that markets a...